Call an insurance medical director to appeal a prior authorization denial for a necessary medication, testing your ability to advocate within a bureaucratic system.
This is an interactive phone call simulation. You'll speak with Dr. Evans in a realistic clinical communication scenario.
Click "Start Call" when you're ready. Speak naturally as you would on a real call.
10 minutes to complete the call. The AI responds in real-time to what you say.
End the call when finished. You'll receive AI-powered feedback on your communication.
💡 Tip: Speak clearly and at a natural pace. If you need a moment to think, it's okay to pause briefly - just as you would in a real conversation.
The peer-to-peer review is a common, often frustrating, part of modern medicine where you must call another physician working for an insurance company to justify a test or treatment. Success in these calls requires a specific skillset: be organized, be concise, and be persistent. You are advocating for your patient against a bureaucratic system.
Key communication strategies include:
You are the primary care physician. Your request for prior authorization for a GLP-1 agonist (like semaglutide) for your patient with Type 2 Diabetes and heart disease was denied. The insurance company requires you to use an older, less effective medication first. Your objective is to call the insurance medical director, Dr. Evans, and conduct a peer-to-peer review to get the denial overturned.
Your patient is a 65-year-old man with a 10-year history of Type 2 Diabetes, a history of a prior heart attack (MI), and a BMI of 35. His A1c is 8.5% despite being on metformin and a sulfonylurea.
Optional prep details
Optional self-check before you start
This scenario requires an account. Sign in to begin the simulation.
After completing this scenario, you will be able to:
When preparing for a peer-to-peer call, which of the following is the MOST critical set of information to have immediately available?
What is the most effective opening strategy for a peer-to-peer call?
If the insurance reviewer denies a medication stating 'failure to complete step therapy,' what is the strongest counter-argument?